Cargando…

The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia

Background: In recent decades, research on drug therapy for ventilator-associated pneumonia (VAP) remains one of the major hot-spots in the field of critical care medicine, but relevant data are not satisfactory. Our aim was to assess the status and trends of the most cited articles on drug therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao-Yang, Li, Bing-Hui, Ma, Lin-Lu, Zhao, Ming-Juan, Deng, Tong, Jin, Ying-Hui, Ren, Xue-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379351/
https://www.ncbi.nlm.nih.gov/pubmed/30809150
http://dx.doi.org/10.3389/fphar.2019.00108
_version_ 1783396064098779136
author Wang, Chao-Yang
Li, Bing-Hui
Ma, Lin-Lu
Zhao, Ming-Juan
Deng, Tong
Jin, Ying-Hui
Ren, Xue-Qun
author_facet Wang, Chao-Yang
Li, Bing-Hui
Ma, Lin-Lu
Zhao, Ming-Juan
Deng, Tong
Jin, Ying-Hui
Ren, Xue-Qun
author_sort Wang, Chao-Yang
collection PubMed
description Background: In recent decades, research on drug therapy for ventilator-associated pneumonia (VAP) remains one of the major hot-spots in the field of critical care medicine, but relevant data are not satisfactory. Our aim was to assess the status and trends of the most cited articles on drug therapy for VAP through bibliometric approaches. Methods: The Institute for Scientific Information (ISI) Web of Science core collection database was searched for the VAP-related articles. The time period for retrieval was from the beginning of the database to September 30, 2018. The top 100 most cited articles were selected to obtain their information on the authors, title, publication, number of citations, author’s affiliations, country, etc. These general information and bibliometric data were collected for analysis. VOSviewer software was used to generate a term co-occurrence graph that visualized a reference pattern for different terms in the 100 articles. Results: The number of citations for the 100 selected articles ranged from 142 to 3,218. These articles were published in 31 different journals. The top three journals in terms of the number of our selected articles they published were “Critical Care Medicine” (17 articles), “American Journal of Respiratory and Critical Care Medicine” (11 articles) and “Clinical Infectious Diseases” (10 articles). The most frequently nominated author was Marin H. Kollef from the University of Washington, and of the top 100 articles, 16 listed his name. These top 100 articles were published after the year of 2000. The most common type of article in the top 100 was an original article (53%). The United States and France were the countries that contributed the most articles to the top 100. Gram-negative bacilli, pseudomonas aeruginosa, antibiotics, risk factors and other terms appeared more frequently, suggesting that attentions on this issue currently focused on the rational application and management of antibiotics. Conclusion: This study analyzed the 100 most cited articles on drug-treated VAP, and provided insights into the historical developments and characteristics of the most cited articles in the field of VAP.
format Online
Article
Text
id pubmed-6379351
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63793512019-02-26 The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia Wang, Chao-Yang Li, Bing-Hui Ma, Lin-Lu Zhao, Ming-Juan Deng, Tong Jin, Ying-Hui Ren, Xue-Qun Front Pharmacol Pharmacology Background: In recent decades, research on drug therapy for ventilator-associated pneumonia (VAP) remains one of the major hot-spots in the field of critical care medicine, but relevant data are not satisfactory. Our aim was to assess the status and trends of the most cited articles on drug therapy for VAP through bibliometric approaches. Methods: The Institute for Scientific Information (ISI) Web of Science core collection database was searched for the VAP-related articles. The time period for retrieval was from the beginning of the database to September 30, 2018. The top 100 most cited articles were selected to obtain their information on the authors, title, publication, number of citations, author’s affiliations, country, etc. These general information and bibliometric data were collected for analysis. VOSviewer software was used to generate a term co-occurrence graph that visualized a reference pattern for different terms in the 100 articles. Results: The number of citations for the 100 selected articles ranged from 142 to 3,218. These articles were published in 31 different journals. The top three journals in terms of the number of our selected articles they published were “Critical Care Medicine” (17 articles), “American Journal of Respiratory and Critical Care Medicine” (11 articles) and “Clinical Infectious Diseases” (10 articles). The most frequently nominated author was Marin H. Kollef from the University of Washington, and of the top 100 articles, 16 listed his name. These top 100 articles were published after the year of 2000. The most common type of article in the top 100 was an original article (53%). The United States and France were the countries that contributed the most articles to the top 100. Gram-negative bacilli, pseudomonas aeruginosa, antibiotics, risk factors and other terms appeared more frequently, suggesting that attentions on this issue currently focused on the rational application and management of antibiotics. Conclusion: This study analyzed the 100 most cited articles on drug-treated VAP, and provided insights into the historical developments and characteristics of the most cited articles in the field of VAP. Frontiers Media S.A. 2019-02-12 /pmc/articles/PMC6379351/ /pubmed/30809150 http://dx.doi.org/10.3389/fphar.2019.00108 Text en Copyright © 2019 Wang, Li, Ma, Zhao, Deng, Jin and Ren. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Chao-Yang
Li, Bing-Hui
Ma, Lin-Lu
Zhao, Ming-Juan
Deng, Tong
Jin, Ying-Hui
Ren, Xue-Qun
The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
title The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
title_full The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
title_fullStr The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
title_full_unstemmed The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
title_short The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
title_sort top-100 highly cited original articles on drug therapy for ventilator-associated pneumonia
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379351/
https://www.ncbi.nlm.nih.gov/pubmed/30809150
http://dx.doi.org/10.3389/fphar.2019.00108
work_keys_str_mv AT wangchaoyang thetop100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT libinghui thetop100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT malinlu thetop100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT zhaomingjuan thetop100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT dengtong thetop100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT jinyinghui thetop100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT renxuequn thetop100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT wangchaoyang top100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT libinghui top100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT malinlu top100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT zhaomingjuan top100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT dengtong top100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT jinyinghui top100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia
AT renxuequn top100highlycitedoriginalarticlesondrugtherapyforventilatorassociatedpneumonia